Comparison of minimal residual disease detection in multiple myeloma between SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry methods

被引:0
|
作者
Takamatsu, Hiroyuki [1 ]
Yoroidaka, Takeshi [1 ]
Fujisawa, Momoko [1 ]
Kobori, Kazuya [2 ]
Hanawa, Masako [2 ]
Yamashita, Takeshi [3 ]
Murata, Ryoichi [3 ]
Ueda, Mikio [3 ]
Nakao, Shinji [1 ]
Matsue, Kosei [4 ]
机构
[1] Kanazawa Univ, Kanazawa, Ishikawa, Japan
[2] SRL Inc, Tokyo, Japan
[3] Keiju Kanazawa Hosp, Kanazawa, Ishikawa, Japan
[4] Kameda Med Ctr, Kamogawa, Japan
来源
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词
Minimal residual disease; multiparameter flow cytometry;
D O I
10.1016/j.clml.2019.09.307
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
FP-222
引用
收藏
页码:E183 / E184
页数:2
相关论文
共 50 条
  • [21] A Single-Tube Seven-Colour Flow Cytometry Assay for Detection of Minimal Residual Disease In Myeloma.
    Wuilleme, Soraya
    Robillard, Nelly
    Richebourg, Steven
    Eveillard, Marion
    Lode, Laurence
    Avet-Loiseau, Herve
    BLOOD, 2010, 116 (21) : 708 - 708
  • [22] A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma
    de Tute, R. M.
    Jack, A. S.
    Child, J. A.
    Morgan, G. J.
    Owen, R. G.
    Rawstron, A. C.
    LEUKEMIA, 2007, 21 (09) : 2046 - U2
  • [23] A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma
    R M de Tute
    A S Jack
    J A Child
    G J Morgan
    R G Owen
    A C Rawstron
    Leukemia, 2007, 21 : 2046 - 2049
  • [24] Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods
    Takeshi Yoroidaka
    Kentaro Narita
    Hiroyuki Takamatsu
    Momoko Fujisawa
    Shinji Nakao
    Kosei Matsue
    Scientific Reports, 11
  • [25] NEW STRATEGIES OF MINIMUM RESIDUAL DISEASE ANALYSIS IN ACUTE MYELOBLASTIC LEUKEMIA BY 8-COLOR FLOW CYTOMETRY IN THE AGE OF STANDARDIZATION
    Sarmiento Palao, H.
    Diaz Rodriguez, V
    Lopez Marin, J.
    Lopez Castano, F.
    Arranz Oliva, E.
    Manresa Manresa, P.
    Perez Sala, M.
    Garcia Hernandez, C.
    Gil Cortes, C.
    Botella Prieto, C.
    Verdu Belmar, J. J.
    De Paz Andres, F. J.
    Fernandez Abellan, P.
    Marco Vera, P.
    Ruiz Sogorb, P.
    Cobo, J.
    Tarin Rodrigo, F.
    HAEMATOLOGICA, 2018, 103 : 49 - 50
  • [26] Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods
    Yoroidaka, Takeshi
    Narita, Kentaro
    Takamatsu, Hiroyuki
    Fujisawa, Momoko
    Nakao, Shinji
    Matsue, Kosei
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [27] Association of Minimal Residual Disease by a Single-Tube 8-Color Flow Cytometric Analysis With Clinical Outcome in Adult B-Cell Acute Lymphoblastic Leukemia A Real-World Study Based on 486 Patients
    Liao, Hongyan
    Jiang, Nenggang
    Yang, Ying
    Zhang, Xin
    Chen, Jiao
    Lai, Hongli
    Zheng, Qin
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2023, 147 (10) : 1186 - 1195
  • [28] OPTIMIZATION OF MINIMAL RESIDUAL DISEASE DETECTION BY MULTI-COLOR FLOW CYTOMETRY IN MULTIPLE MYELOMA: 8 COLORS AND BEYOND.
    Kozanoglu, Ilknur
    Buyukkurt, Nurhilal
    Unver, Gulsah
    Aytan, Pelin
    Yeral, Mahmut
    Boga, Can
    Ozdogu, Hakan
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 : 62 - 63
  • [29] Prospective Comparison Study of Prognostic Value of MRD Detected By 8-Color MFC (EuroFlow-NGF) and NGS in Patients with Multiple Myeloma in ASCT Setting
    Yoroidaka, Takeshi
    Takamatsu, Hiroyuki
    Itagaki, Mitsuhiro
    Yoshihara, Satoshi
    Sato, Kota
    Takezako, Naoki
    Ozaki, Shuji
    Suzuki, Kazuhito
    Kohno, Kentaro
    Matsumoto, Morio
    Terasaki, Yasushi
    Yamashita, Takeshi
    Fuchida, Shin-ichi
    Urushihara, Ryota
    Hiragori, Yuji
    Suzuki, Kenshi
    Murakami, Hirokazu
    Nakao, Shinji
    Durie, Brian G. M.
    Shimizu, Kazuyuki
    BLOOD, 2021, 138
  • [30] THE RATIO OF PATHOLOGICAL PLASMOCYTES, ASSESSED BY 8-COLOR FLOW CYTOMETRY, PREDICTS OF RISK OF EVOLUTION IN MONOCLONAL GAMMOPATHY OF UNKNOWN SIGNIFICANCE AND SMOULDERING MULTIPLE MYELOMA
    Brouzes, C.
    Lhermitte, L.
    Zaratzian, C.
    Chandesris, M. O.
    Frenzel, L.
    Delarue, R.
    Suarez, F.
    Hermine, O.
    Macintyre, E.
    Asnafi, V.
    HAEMATOLOGICA, 2017, 102 : 506 - 506